FDA Panel Votes To Restrict Acetaminophen
Links shared publicly online about this topic.
- 1,926total visits
FDA Panel Votes To Restrict Acetaminophen
View full resource at medicalnewstoday.com
Tags: FDA, Analgesic Medication, Acetaminophen, Tylenol, Feverall, Tempra, Panadol, Aspirin-Free Anacin
Most Recently Shared on July 2, 2009 at 9:08 pm By:
FDA Panel Votes To Restrict Acetaminophen: An advisory committee to the US Food and Drug Administration (FDA) vo.. http://bit.ly/1u0yF
FDA panel votes 9-2 in favor of new blood thinner drug
news-medical.net — “A new stroke preventer from Bayer and Johnson & Johnson – Xarelto moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the need for more studies.” View full resource at news-medical.net
Most Recently Shared on September 10, 2011 at 1:56 am By:
Drugs and Devices OW OW Health
FDA panel votes 9-2 in favor of new blood thinner drug - News-Medical.net: USA TodayFDA panel votes 9-2 in... http://t.co/Y0EipDF #drug
A.M. Vitals: FDA Panel Votes Against Diabetes Drug From Bristol, Astra - Health Blog - WSJ
blogs.wsj.com — “Also: VC investments in biotech; earnings from UnitedHealth and J&J; Ivy League to restrict full-contact football practices.” View full resource at blogs.wsj.com
Most Recently Shared on July 20, 2011 at 1:52 pm By:
A.M. Vitals: FDA Panel Votes Against Diabetes Drug From Bristol, Astra http://t.co/ARRBf3j
FDA Considering Adding Dosage for Kids Under 2 to Infant and Children's Tylenol - Childrens Tylenol Dosage - Parenting.com
parenting.com — “Has this ever happened to you? You--™ve got a feverish, uncomfortable baby at 3am; you dig out the Infant Tylenol--and the bottle says to consult a physician for the correct dosage. Not helpful. Now that might be about to change. An FDA advisory panel has voted to put dosing information for kids under 2 on the packaging of Infants--™ and Children--™s Tylenol and other over-the-counter acetaminophen products to help confused parents” View full resource at parenting.com
Most Recently Shared on May 19, 2011 at 1:37 pm By:
Finally. FDA votes to add dosage for kids under 2 to Infant and Children’s Tylenol packaging: http://bit.ly/jHtjCB
Panel backs dosing instructions for acetaminophen
pediatricsupersite.com — “An FDA advisory committee voted today to recommend dosing instructions on products containing acetaminophen, specifically dosing instructions fo” View full resource at pediatricsupersite.com
Most Recently Shared on May 18, 2011 at 10:20 pm By:
Thomas Loarie, Jr Health Advocate
@PedSuperSite Panel backs dosing instructions for acetaminophen: http://bit.ly/l0LrCL #kids #parenting
Add Dosing Instructions To Acetaminophen For Children Under 2, Says FDA Advisory Panel
medicalnewstoday.com — “An FDA Advisory Committee says that acetaminophen for children under the age of two should have dosing instructions added to the labels. The 21-0 vote referred to dosing information specifically f” View full resource at medicalnewstoday.com
Most Recently Shared on May 18, 2011 at 6:05 pm By:
MNT Drug Approvals Health News
Add Dosing Instructions To Acetaminophen For Children Under 2, Says FDA Advisory Panel http://mnt.to/3W3Z #regulatory
Hospital Medicine Quick Hits » Blog Archive » FDA limits on acetaminophen
blogs.hospitalmedicine.org — “Hospital Medicine Quick Hits » Blog Archive » FDA limits on acetaminophen” View full resource at blogs.hospitalmedicine.org
Most Recently Shared on January 15, 2011 at 6:03 am By:
Wiley Health Medical Health Site
FDA limits on acetaminophen: The FDA has voted to restrict the amount of acetaminophen in opiate combinations to... http://bit.ly/hDYgRL
A Best Case Scenario For Amgen’s Anemia Drugs - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “A panel of Food and Drug Administration advisers voted not to restrict the use of anemia drugs like Epogen and Aranesp in kidney disease patients, either before they start getting dialysis or when they get it (a $2.6 billion market.) This basically represents a best-case scenario after a large clinical [...]” View full resource at blogs.forbes.com
Most Recently Shared on October 18, 2010 at 9:48 pm By:
Drugs and Devices OW OW Health
A Best Case Scenario For Amgen's Anemia Drugs: An FDA meeting on Amgen's anemia drugs went basically as well ... http://bit.ly/beVv0v #drug
UPDATE 2-US FDA panel split over fate of Abbott diet drug | Reuters
reuters.com — “* FDA panel splits vote on whether to urge Meridia ban * Abbott seeks stronger warning, restricted sales * U.S. obesity drug market nearly $400 mln annually * Industry concerned about wider impact” View full resource at reuters.com
Most Recently Shared on September 17, 2010 at 8:23 pm By:
Susan Krauss Whitbourne Doctor, Psychologist, and PhD
#Diet drug not doing so well. If only they'd invent an #exercise drug instead. http://ow.ly/2G21w
Meridia risks warrant restrictions or withdrawal: FDA panel | theheart.org
theheart.org — “UPDATED // Six members of the FDA panel voted to recommend that the FDA severely restrict access to the weight-loss drug, and eight recommended the plug be pulled on it altogether. Only two on the panel reviewing the SCOUT trial concluded that the drug should remain on the market with a boxed warning only, and no members thought the drug could stay with no labeling changes.” View full resource at theheart.org
Most Recently Shared on September 15, 2010 at 8:58 pm By:
Full story on today's #Meridia / sibutramine FDA advisory meeting now @ theheart.org http://www.theheart.org/article/1122267.do
Medical News: FDA Panel Wants Tougher Restrictions on Opioids - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “ADELPHI, Md. -- An FDA advisory committee voted 25-10 to reject the agency's proposed plan to prevent inappropriate prescribing, misuse, and abuse of extended-release opioid painkillers, saying the pl” View full resource at medpagetoday.com
Most Recently Shared on July 24, 2010 at 3:07 am By:
FDA Panel Wants Tougher Restrictions on Opioids http://bit.ly/c2ADtZ
HealthScout-Consumer Health News, Information and Resources Updated Daily-Heart-Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds
healthscout.com — “Consumer Health News, Information and Resources Updated Daily - Consumer Health Information by HealthScout,Experts vote for tightened controls or restricted sales on diabetes drug” View full resource at healthscout.com
Most Recently Shared on July 16, 2010 at 12:59 am By:
Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds http://tinyurl.com/33wg5of
FDA Panel Issues Recommendation on Avandia :: Diabetes Self-Management
diabetesselfmanagement.com — “A Food and Drug Administration (FDA) advisory panel voted on Wednesday to allow the controversial diabetes drug Avandia (rosiglitazone) to remain on the market, but about half of the panel members called for sales restrictions and/or stronger label warnings about the risk of heart attacks...” View full resource at diabetesselfmanagement.com
Most Recently Shared on July 15, 2010 at 8:27 pm By:
Diabetes Self-Mgmt Health Site
Yesterday, an FDA panel issued recommendations on #Avandia. Find out what it advised—and how Avandia got here. http://bit.ly/bIrRiW
FDA panel's vote on Avandia reveals mixed opinions on diabetes drug's safety
washingtonpost.com — “Federal advisers delivered a mixed verdict Wednesday on the diabetes drug Avandia, with a significant number of experts voting to recommend that it be pulled from the market because of safety concerns but a majority urging to keep it available, perhaps with tough new restrictions and new warnings.” View full resource at washingtonpost.com
Most Recently Shared on July 15, 2010 at 3:38 pm By:
FDA review panel shows mixed opinions about whether Avandia should be withdrawn from sale. http://bit.ly/dyDzcq
FDA panel: Keep rosiglitazone on market, but with more warnings, restrictions
endocrinetoday.com — “An FDA advisory committee has recommended that rosiglitazone stay on the U.S. market as a treatment option for patients with type 2 diabetes, bu” View full resource at endocrinetoday.com
Most Recently Shared on July 15, 2010 at 2:48 pm By:
Endo Today's re-cap of the #FDA #rosiglitazone vote: http://ow.ly/2bUAP
F.D.A. Panel to Vote on Whether Avandia Should Stay on Market - NYTimes.com
nytimes.com — “The majority of panel members voted either to withdraw the diabetes drug Avandia or allow sales with controls.” View full resource at nytimes.com
Most Recently Shared on July 15, 2010 at 1:37 pm By:
Virtual Mentor Medical Journal
F.D.A. Panel Votes to Restrict Diabetes Drug Avandia http://nyti.ms/dvEOAu
Advertisement
